Relative Strengths of Three Linearizations of Receptor Availability: Saturation, Inhibition, and Occupancy Plots.
Lassen plots
PET
binding potential
inhibition plot
Journal
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
received:
15
12
2020
revised:
23
04
2021
pubmed:
6
6
2021
medline:
30
4
2022
entrez:
5
6
2021
Statut:
ppublish
Résumé
We derived three widely used linearizations from the definition of receptor availability in molecular imaging with positron emission tomography (PET). The purpose of the present research was to determine the convergence of the results of the 3 methods in terms of 3 parameters-occupancy (s), distribution volume of the nondisplaceable reference binding compartment (V
Identifiants
pubmed: 34088774
pii: jnumed.117.204453
doi: 10.2967/jnumed.117.204453
pmc: PMC8805780
doi:
Substances chimiques
Radiopharmaceuticals
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
294-301Informations de copyright
© 2022 by the Society of Nuclear Medicine and Molecular Imaging.
Références
Synapse. 2011 Oct;65(10):991-7
pubmed: 21360596
J Cereb Blood Flow Metab. 2010 Jan;30(1):46-50
pubmed: 19738632
Semin Roentgenol. 2001 Jul;36(3):250-60
pubmed: 11475071
Neuropsychopharmacology. 2013 Feb;38(3):504-12
pubmed: 23132267
J Cereb Blood Flow Metab. 1986 Apr;6(2):137-46
pubmed: 2937794
Ann Neurol. 1984 Mar;15(3):217-27
pubmed: 6609679
Int J Neuropsychopharmacol. 2018 Jul 1;21(7):656-667
pubmed: 29522184
J Cereb Blood Flow Metab. 2011 Jan;31(1):243-9
pubmed: 20571518
J Cereb Blood Flow Metab. 2007 Sep;27(9):1533-9
pubmed: 17519979
J Cereb Blood Flow Metab. 2014 Jun;34(6):989-94
pubmed: 24643083
Mol Imaging Biol. 2013 Dec;15(6):730-8
pubmed: 23660769
J Cereb Blood Flow Metab. 2020 Sep;40(9):1859-1868
pubmed: 31506011
Mol Imaging Biol. 2015 Jun;17(3):364-72
pubmed: 25449772
J Nucl Med. 2014 Apr;55(4):672-7
pubmed: 24556591
Neuroimage. 2014 Oct 1;99:69-79
pubmed: 24844744
J Cereb Blood Flow Metab. 2017 Aug;37(8):2716-2727
pubmed: 27742888
Synapse. 2011 Nov;65(11):1119-27
pubmed: 21538549
Mol Imaging. 2014;13:1-12
pubmed: 24824855
Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):396-406
pubmed: 30121895
EJNMMI Res. 2012 Jul 09;2(1):37
pubmed: 22776065
Int Rev Neurobiol. 2005;63:1-20
pubmed: 15797463
Neuroimage. 2013 Nov 15;82:160-9
pubmed: 23668965
J Cereb Blood Flow Metab. 1995 Jan;15(1):152-65
pubmed: 7798333
Sci Rep. 2017 Nov 22;7(1):15979
pubmed: 29167492
J Cereb Blood Flow Metab. 2015 Mar;35(3):501-11
pubmed: 25564241
J Cereb Blood Flow Metab. 2018 May;38(5):881-887
pubmed: 28509598
J Cereb Blood Flow Metab. 2012 Apr;32(4):731-44
pubmed: 22214903
J Nucl Med. 2014 Feb;55(2):315-20
pubmed: 24434292
J Nucl Med. 2011 Sep;52(9):1449-56
pubmed: 21828113
J Nucl Med. 2012 Nov;53(11):1723-9
pubmed: 22966134
Bull Math Biol. 2019 Sep;81(9):3508-3541
pubmed: 29230702
Eur J Nucl Med Mol Imaging. 2016 Mar;43(3):537-47
pubmed: 26455500
Stat Med. 1990 Dec;9(12):1463-73
pubmed: 2281234
Int J Neuropsychopharmacol. 2013 Jul;16(6):1231-9
pubmed: 23217964